Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Admission to Trading

1 Apr 2026 12:26

RNS Number : 1037Z
Softcat PLC
01 April 2026
 

1 April 2026

 

 

Softcat plc ("Softcat" or "the Company")

NOTIFICATION OF ADMISSION OF FURTHER SECURITIES TO TRADING

 

In accordance with PRM 1.6.4R, Softcat plc (the "Company") announces that it has issued and allotted 44,646 ordinary shares of 0.0005 pence per share between 3 February 2026 and 26 March 2026 in connection with the Softcat plc Long Term Incentive Plan.

 

For completeness, 210,189 ordinary shares of 0.0005 pence per share were issued in connection with the Softcat plc Long Term Incentive Plan between 3 December 2025 and 15 January 2026, following the last block listing return for the six-months ended 13 November 2025.

 

These shares were previously admitted to trading on the London Stock Exchange Main Market under two existing block admissions to trading in June 2021 and November 2025.

 

1.

Details of the issuer

a)

Name

Softcat plc

b)

LEI

213800N42YZLR9GLVC42

 

Details of the transferable securities admitted to trading

2.

Regulated market

XLON

3.

Name, type andidentification code

Ordinary shares of 0.0005 pence each

GB00BYZDVK82

4.

Number of further securities admitted

44,646

5.

Total number of securities in issue following admission

196,850,184

6.

Confirmation that the shares are fungible with existing ordinary shares

Confirmed

Admission details

7.

Date range of admission

03/02/26 - 26/03/26

8.

Prospectus information

N/A

 

 

For further information please contact:

 

Luke Thomas,Company SecretarySoftcat plc Tel: +44 (0) 1628 403 403

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ADMUAUARNVUSRAR
Date   Source Headline
8th Jan 20252:02 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:52 amRNSTotal Voting Rights
12th Dec 20243:07 pmRNSDirector/PDMR Shareholding
10th Dec 20243:40 pmRNSDirector/PDMR Shareholding
10th Dec 202412:54 pmRNSResult of AGM
4th Dec 20242:22 pmRNSDirector/PDMR Shareholding
2nd Dec 202412:11 pmRNSTotal Voting Rights
26th Nov 202410:47 amRNSDirector/PDMR Shareholding
26th Nov 202410:45 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSQ1 2025 Trading Update
18th Nov 20241:55 pmRNSBlock listing Interim Review
11th Nov 20243:31 pmRNSDirector/PDMR Shareholding
1st Nov 20242:36 pmRNSAnnual Financial Report
1st Nov 20249:19 amRNSTotal Voting Rights
24th Oct 20247:00 amRNSFinal Results
14th Oct 202410:01 amRNSHolding(s) in Company
8th Oct 20243:06 pmRNSDirector/PDMR Shareholding
7th Oct 20242:28 pmRNSNotice of Results
1st Oct 20242:37 pmRNSTotal Voting Rights
26th Sep 20249:34 amRNSHolding(s) in Company
16th Sep 20249:41 amRNSHolding(s) in Company
13th Sep 202410:21 amRNSHolding(s) in Company
11th Sep 20249:26 amRNSDirector/PDMR Shareholding
22nd Aug 20249:30 amRNSHolding(s) in Company
9th Aug 202410:45 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSTotal Voting Rights
24th Jul 20249:32 amRNSHolding(s) in Company
9th Jul 202412:29 pmRNSDirector/PDMR Shareholding
1st Jul 20249:17 amRNSTotal Voting Rights
10th Jun 202412:53 pmRNSChange of Adviser
10th Jun 202411:24 amRNSDirector/PDMR Shareholding
3rd Jun 20249:26 amRNSTotal Voting Rights
28th May 20247:00 amRNSQ3 2024 Trading Update
23rd May 202410:02 amRNSBlock listing Interim Review
10th May 20242:25 pmRNSDirector/PDMR Shareholding
9th May 20243:09 pmRNSDirector/PDMR Shareholding
1st May 202410:50 amRNSTotal Voting Rights
9th Apr 20249:45 amRNSDirector/PDMR Shareholding
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20241:00 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSHalf-year Report
15th Mar 20242:45 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSNotice of Results
1st Mar 20242:28 pmRNSHolding(s) in Company
1st Mar 202410:47 amRNSTotal Voting Rights
8th Feb 20249:34 amRNSDirector/PDMR Shareholding
1st Feb 20249:49 amRNSTotal Voting Rights
30th Jan 20249:58 amRNSHolding(s) in Company
9th Jan 20243:48 pmRNSDirector/PDMR Shareholding
9th Jan 202412:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.